China Regenerative Medicine International Limited (HKG:8158)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.3600
-0.0150 (-4.00%)
Feb 13, 2026, 4:08 PM HKT

HKG:8158 Income Statement

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
58.2290.6269.4941.54282.9182.14
Revenue Growth (YoY)
5.75%30.41%67.29%-85.32%55.32%840.54%
Cost of Revenue
22.1832.9650.063.91215.17140.33
Gross Profit
36.0557.6519.4237.6267.7341.81
Selling, General & Admin
47.0151.5245.5425.8247.4546.95
Operating Expenses
65.0351.5245.5425.826.0947.61
Operating Income
-28.986.14-26.1111.8161.63-5.8
Interest Expense
-1.15-1.13-0.98-0.78-0.74-17.91
Interest & Investment Income
18.817.580.0100.010.02
Other Non Operating Income (Expenses)
12.57-4.87-80.66-3.67-1.67-25.18
EBT Excluding Unusual Items
1.2317.72-107.747.3559.24-48.86
Gain (Loss) on Sale of Investments
-----2.34
Other Unusual Items
0.040.040.040.915.05-95.58
Pretax Income
1.2717.75-107.78.2764.29-142.1
Income Tax Expense
---3.7112.4712.38
Earnings From Continuing Operations
1.2717.75-107.74.5651.83-154.48
Earnings From Discontinued Operations
------284.35
Net Income to Company
1.2717.75-107.74.5651.83-438.83
Minority Interest in Earnings
-----34.6
Net Income
1.2717.75-107.74.5651.83-404.23
Net Income to Common
1.2717.75-107.74.5651.83-404.23
Net Income Growth
----91.21%--
Shares Outstanding (Basic)
304304286285285161
Shares Outstanding (Diluted)
304304286285285161
Shares Change (YoY)
2.85%6.23%0.34%-77.64%82.73%
EPS (Basic)
0.000.06-0.380.020.18-2.52
EPS (Diluted)
0.000.06-0.380.020.18-2.52
EPS Growth
----91.21%--
Free Cash Flow
2.3617.6810.52-15.03-3.83-399.15
Free Cash Flow Per Share
0.010.060.04-0.05-0.01-2.48
Gross Margin
61.91%63.62%27.95%90.58%23.94%22.95%
Operating Margin
-49.78%6.77%-37.58%28.42%21.79%-3.19%
Profit Margin
2.18%19.59%-154.99%10.97%18.32%-221.94%
Free Cash Flow Margin
4.04%19.51%15.13%-36.17%-1.35%-219.15%
EBITDA
-28.46.8-25.5411.9861.71-4.07
EBITDA Margin
-48.78%7.50%-36.75%28.83%21.81%-2.24%
D&A For EBITDA
0.580.660.570.170.081.73
EBIT
-28.986.14-26.1111.8161.63-5.8
EBIT Margin
-49.78%6.77%-37.58%28.42%21.79%-3.19%
Effective Tax Rate
---44.90%19.39%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.